Abstract
Elizabethkingia miricola is an emerging opportunistic pathogen that can cause severe infections in both amphibians and humans, but the genomic basis of its pathogenicity and the host immune response during infection remain incompletely understood. In this study, whole-genome sequencing, antimicrobial susceptibility testing, and splenic transcriptome analysis were integrated to systematically characterize the genomic features, antimicrobial resistance profile, virulence factors, and early host immune responses of E. miricola strain PN-EM1 isolated from diseased black-spotted frogs (Pelophylax nigromaculatus). The genome of PN-EM1 consists of one circular chromosome of 4,260,425 bp, encoding 3906 protein-encoding genes, with a GC content of 36.71%. Antimicrobial susceptibility testing confirmed that PN-EM1 was resistant to 18 of the 31 antibiotics tested (58.1%), exhibiting a multidrug-resistant phenotype. Splenic transcriptome sequencing yielded high-quality clean data. Compared with the PBS-injected control group, a total of 1237 differentially expressed genes (DEGs) were identified in spleen tissue from E. miricola-infected frogs, including 393 upregulated and 844 downregulated genes. These genes were significantly enriched in cell adhesion molecules and antigen processing and presentation pathways. This study characterized the multidrug resistance mechanisms, virulence potential, and splenic immune response patterns of E. miricola PN-EM1, which may inform the diagnosis, prevention, and rational medication of E. miricola infection in frog farming.